Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

[1]  A. Quayle,et al.  Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone1 , 2005, Biology of reproduction.

[2]  J. R. Johnson,et al.  Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. , 2005, The Journal of infectious diseases.

[3]  W. Bossart,et al.  Protection by a polyvalent vaccine against challenge infection and pyelonephritis , 2004, Urological Research.

[4]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. , 2003, Infectious disease clinics of North America.

[5]  D. Uehling,et al.  Vaccine development for the prevention of urinary tract infections , 2002, Current infectious disease reports.

[6]  W. Stamm,et al.  Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Clyde Thornsberry,et al.  Multidrug-Resistant Urinary Tract Isolates ofEscherichia coli: Prevalence and Patient Demographics in the United States in 2000 , 2001, Antimicrobial Agents and Chemotherapy.

[8]  D. Heisey,et al.  Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. , 2001, The Journal of infectious diseases.

[9]  A. Messina,et al.  Immunosenescence: a review. , 2001, Archives of gerontology and geriatrics.

[10]  O. Clermont,et al.  Rapid and Simple Determination of theEscherichia coli Phylogenetic Group , 2000, Applied and Environmental Microbiology.

[11]  D. Heisey,et al.  Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. , 1997, The Journal of urology.

[12]  E. Balish,et al.  Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection. , 1994, The Journal of urology.

[13]  E. Balish,et al.  Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine. , 1994, The Journal of urology.

[14]  E. Balish,et al.  Immunization against urinary tract infection with a multi-valent vaginal vaccine. , 1991, The Journal of urology.

[15]  E. Balish,et al.  Local and systemic antibody responses accompany spontaneous resolution of experimental cystitis in cynomolgus monkeys , 1987, Infection and immunity.

[16]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .